Vault-13

SR One Capital Management, LP

Redwood City, CA · CIK 1910264 · 13F filing filed 2026-08-12

SEC-registered investment adviser since 2020 · limited partnership

$1.0bn reported value +13.5% vs Q1 2026
15positions
95.1%in top 10
3 new 1 added 0 reduced 2 sold out vs Q1 2026

Holdings, Q2 2026

The small lines show how much was held over the last 4 quarters (adjusted for stock splits).

#SecurityTickerShares Value% of portfolioChangeShares change
1 VERADERMICS INC COMMON STOCK MANE MANE 2,401,868 $295.3m28.42% 28.42% UnchangedShares held: Q3 2025 0, Q4 2025 0, Q1 2026 2.4m, Q2 2026 2.4m
2 ZENAS BIOPHARMA INC COM ZBIO ZBIO 5,037,854 $127.9m12.31% 12.31% UnchangedShares held: Q3 2025 4.9m, Q4 2025 5.0m, Q1 2026 5.0m, Q2 2026 5.0m
3 CRISPR THERAPEUTICS AG NAMEN AKT CRSP CRSP 2,038,763 $111.2m10.70% 10.70% UnchangedShares held: Q3 2025 2.0m, Q4 2025 2.0m, Q1 2026 2.0m, Q2 2026 2.0m
4 AVALYN PHARMACEUTICALS INC COM SHS AVLN AVLN 3,308,649 $108.9m10.48% 10.48% NewShares held: Q3 2025 0, Q4 2025 0, Q1 2026 0, Q2 2026 3.3m
5 DESIGN THERAPEUTICS INC COM DSGN DSGN 6,526,476 $94.4m9.09% 9.09% UnchangedShares held: Q3 2025 6.5m, Q4 2025 6.5m, Q1 2026 6.5m, Q2 2026 6.5m
6 ODYSSEY THERAPEUTICS INC COMMON STOCK ODTX ODTX 3,794,883 $71.0m6.83% 6.83% NewShares held: Q3 2025 0, Q4 2025 0, Q1 2026 0, Q2 2026 3.8m
7 ALUMIS INC COM ALMS ALMS 1,959,896 $55.2m5.31% 5.31% UnchangedShares held: Q3 2025 2.0m, Q4 2025 2.0m, Q1 2026 2.0m, Q2 2026 2.0m
8 ORIC PHARMACEUTICALS INC COM ORIC ORIC 4,615,384 $50.0m4.81% 4.81% AddedShares held: Q3 2025 4.5m, Q4 2025 4.5m, Q1 2026 4.5m, Q2 2026 4.6m +100.5k +100,455 2.2%
9 MINERALYS THERAPEUTICS INC COM MLYS MLYS 1,563,966 $42.2m4.06% 4.06% UnchangedShares held: Q3 2025 2.1m, Q4 2025 1.6m, Q1 2026 1.6m, Q2 2026 1.6m
10 ARS PHARMACEUTICALS INC COM SPRY SPRY 4,012,903 $32.1m3.09% 3.09% UnchangedShares held: Q3 2025 4.0m, Q4 2025 4.0m, Q1 2026 4.0m, Q2 2026 4.0m
11 MOBIA MED INC COMMON STOCK MOBI MOBI 1,986,072 $26.6m2.56% 2.56% NewShares held: Q3 2025 0, Q4 2025 0, Q1 2026 0, Q2 2026 2.0m
12 NKARTA INC COM NKTX NKTX 3,333,333 $9.4m0.91% 0.91% UnchangedShares held: Q3 2025 3.3m, Q4 2025 3.3m, Q1 2026 3.3m, Q2 2026 3.3m
13 OCULIS HOLDING AG ORDINARY SHARES OCS OCS 641,022 $8.9m0.86% 0.86% UnchangedShares held: Q3 2025 322.5k, Q4 2025 641.0k, Q1 2026 641.0k, Q2 2026 641.0k
14 ULTRAGENYX PHARMACEUTICAL IN COM RARE RARE 137,753 $4.6m0.44% 0.44% UnchangedShares held: Q3 2025 0, Q4 2025 137.8k, Q1 2026 137.8k, Q2 2026 137.8k
15 ENGENE HOLDINGS INC COM COM 747,750 $1.3m0.12% 0.12% UnchangedShares held: Q3 2025 747.8k, Q4 2025 747.8k, Q1 2026 747.8k, Q2 2026 747.8k

Sold out since Q1 2026

SecurityTickerShares held beforeValue then
ARCELLX INC ACLX ACLX 2,346,630 $269.4m2.3m shares
ORUKA THERAPEUTICS INC ORKA ORKA 430,330 $21.1m430.3k shares